NCT04526340

Brief Summary

Understanding the impact of food/nutrients on body fluid metabolism is important for improving diagnosis and treatment of nocturia, polyuria in relation to lifestyle interventions. This study on "Food and Salt Handling in Diuresis" examines the role of certain food and nutrients in diuresis. The study design is to investigate the possible acute effects and mechanisms of selected food (which are known to be diuretic) and nutrients (e.g. salt) in diuresis in healthy individuals. The study will provide insights into the management of nocturia, nocturnal polyuria or oedema which are common clinical sign in a wide range of disorders as cardiovascular, renal and metabolic disorders. During the study the volunteers will be asked to ingest a certain dosage of a food/nutrient in capsules along with a defined amount of water (500 ml). 2 Blood and 3 urine samples will be collected at different time points to measure the urine output and urine composition derived by the ingestion of the particular food item. Renal Function Profiling is used as an easy and cheap tool to understand the mechanism of action behind the observed effect in diuresis. Renal function profiles distinguish the osmotic form water diuresis from a change in filtration. Bio-electrical impedance analysis (BIA) is also used to evaluate oedema and fluid volumes in body tissues. BIA is a non-invasive technique based on Ohm's law whereby the resistance of a tissue against an electric current is inversely proportional to the water content and directly proportional to the length of the tissue. For the BIA measurement, a device is used in which 8 tactile electrodes are placed: 2 in contact with the thumb and middle finger of each hand, and 2 in contact with the inside and outside of each foot. Before the start of the measurements, the length and body weight are measured. The resistance of the arms, torso and legs is measured at different frequencies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 24, 2019

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 25, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.5 years

First QC Date

August 12, 2020

Last Update Submit

September 5, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in urine volume (production) after ingestion of nutrient/food capsules

    the aim of this outcome is to check the effect on urine production after taking the capsules

    4 hours

  • Change in urine composition after ingestion of nutrient/food capsules

    the aim of this outcome is to check the effect on urine composition after taking the capsules

    4 hours

  • Change in serum composition after ingestion of nutrient/food capsules

    this aims to evaluate the effect in serum composition after taking the pills

    4 hours

Secondary Outcomes (1)

  • Change in body water distribution after ingestion of nutrients/food capsules

    4 hours

Study Arms (2)

Nutrient day

EXPERIMENTAL

on the nutrient day the subjects will take the testing food/nutrient capsules with 500 ml water

Diagnostic Test: Blood sampleDiagnostic Test: Bio-impedance measurement (BIA)Dietary Supplement: Ingestion of testing nutrient/food capsulesDiagnostic Test: Urine sample

Control day

PLACEBO COMPARATOR

on the control day the subjects will take 500 ml water without nutrient/food capsules

Diagnostic Test: Blood sampleDiagnostic Test: Bio-impedance measurement (BIA)Diagnostic Test: Urine sample

Interventions

Blood sampleDIAGNOSTIC_TEST

2 Blood samples at the beginning and end of the test to analyze; Haptoglobin phenotyping, Haptoglobin concemtration (μmol/l) (serum), Sodium (mmol/l) (serum), Osmolality (mOsm/kg) (serum), Urea (g/l) (serum), Creatinine (g/dl) (serum), Potassium (mmol/l) (serum).

Control dayNutrient day

for every 30 minutes for 4 hours

Control dayNutrient day

The subjects will be tested in fasted and sober state in the morning. No food/drink 6 hours prior to the test. The subjects will be asked to take 2 different dosages of testing nutrient along with 500ml of water and only water for the control, on 3 different test days. The testing nutrients will be prepared in 1g capsules.

Nutrient day
Urine sampleDIAGNOSTIC_TEST

3 Urine samples at the beginning, after 2 hrs and at the end of the test to analyze: Total voided volume, Osmolality (mOsm/kg), Creatinine (g/dl), Sodium (mmol/l), Potassium (mmol/l), Urea (g/l)

Control dayNutrient day

Eligibility Criteria

Age20 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male/female
  • Age between 20-35 years
  • No use of medication (except contraception)
  • Have no health issues
  • Not being pregnant or menstruating at the time of the study
  • BMI 18.5 -25 kg / m2
  • No food allergies

You may not qualify if:

  • Volunteers with an implanted electronic device (e.g. Pacemaker)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Urology, Ghent University Hospital

Ghent, 9000, Belgium

Location

MeSH Terms

Conditions

NocturiaPolyuria

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Lower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Karel Everaert, MD, PhD

    University Hospital, Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 25, 2020

Study Start

June 24, 2019

Primary Completion

December 31, 2020

Study Completion

February 28, 2022

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations